CPA1 Antibody (N-term) Blocking Peptide
€363.00
In stock
SKU
AC-BP6560a
Background:
Three different forms of human pancreatic procarboxypeptidase A have been isolated. CPA1 is a monomeric pancreatic exopeptidase involved in zymogen inhibition.
Other Names:
Carboxypeptidase A1, CPA1, CPA
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6560a was selected from the N-term region of human CPA1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: CPA1 (HGNC:2296)
Gene ID: 1357
Primary Accession: P15085
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Three different forms of human pancreatic procarboxypeptidase A have been isolated. CPA1 is a monomeric pancreatic exopeptidase involved in zymogen inhibition.
Other Names:
Carboxypeptidase A1, CPA1, CPA
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6560a was selected from the N-term region of human CPA1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: CPA1 (HGNC:2296)
Gene ID: 1357
Primary Accession: P15085
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review